Biosig Technologies (BSGM) |
4.23 0.04 (0.95%)
|
03-07 03:13 |
Open: |
4.32 |
Pre. Close: |
4.19 |
High:
|
4.32 |
Low:
|
3.81 |
Volume:
|
337,710 |
Market Cap:
|
130M |
|
|
BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut. |
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
4.322 - 4.343 |
4.343 - 4.365 |
Low:
|
3.765 - 3.785 |
3.785 - 3.805 |
Close:
|
4.195 - 4.229 |
4.229 - 4.265 |
|
Technical analysis |
as of: 2021-03-05 5:05:48 PM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 5.86 One year: 6.74 |
Support: |
Support1: 3.81 Support2: 3.17  |
Resistance: |
Resistance1: 5.02 Resistance2: 5.77 |
Pivot: |
4.75  |
Moving Average: |
MA(5): 4.37 MA(20): 4.86 
MA(100): 4.50 MA(250): 6.26  |
MACD: |
MACD(12,26): -0.13 Signal(9): -0.04  |
Stochastic oscillator: |
%K(14,3): 14.41 %D(3): 15.95  |
RSI: |
RSI(14): 37.82  |
52-week: |
High: 12.43 Low: 2.36 Change(%): 21.6 |
Average Vol(K): |
3-Month: 36159 10-Days: 25209 |
|
Price, moving averages and Bollinger Bands |
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.BSGM has closed above bottom band by 18.3%. Bollinger Bands are 4.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Headline News |
Fri, 05 Mar 2021 The Future of Medicine is Here: Bioelectronic Medicine - Benzinga
Thu, 04 Mar 2021 BioSig Technologies (BSGM) Awarded US Patent Claims for its NeuroClear Subsidiary - StreetInsider.com
Wed, 17 Feb 2021 BioSig Technologies taps seasoned life sciences exec Brenda Castrodad to lead HR department - Proactive Investors USA & Canada
Tue, 16 Feb 2021 BioSig Appoints Brenda Castrodad to Lead Human Resources - GlobeNewswire
Wed, 10 Feb 2021 BioSig Technologies says it has entered into three new evaluation agreements for its PURE EP System - Proactive Investors USA & Canada
Wed, 10 Feb 2021 BioSig Technologies, Inc. (NASDAQ:BSGM) Insiders Increased Their Holdings - Simply Wall St
|
Financial Analysis |
Growth |
 |
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
Profitability |
 |
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
Solvency |
 |
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
Efficiency |
 |
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Medical Devices |
Shares Out. (M) |
31 |
Shares Float (M) |
23 |
% Held by Insiders
|
22.01 |
% Held by Institutions
|
18.47 |
Shares Short (K)
|
2,610 |
Shares Short P. Month (K)
|
2,480 |
Stock Financials |
EPS
|
-2.201 |
EPS Est This Year
|
|
EPS Est Next Year
|
|
Book Value (p.s.)
|
0.950 |
Profit Margin
|
|
Operating Margin
|
|
Return on Assets (ttm)
|
-161.4 |
Return on Equity (ttm)
|
-297.6 |
Qtrly Rev. Growth
|
|
Gross Profit (p.s.)
|
|
Sales Per Share
|
|
EBITDA (p.s.)
|
-2.064 |
Qtrly Earnings Growth
|
|
Operating Cash Flow (M)
|
-24 |
Levered Free Cash Flow (M)
|
-5 |
Stock Valuations |
PE Ratio
|
-1.92 |
PEG Ratio
|
|
Price to Book value
|
4.45 |
Price to Sales
|
|
Price to Cash Flow
|
-5.33 |
Stock Dividends |
Dividend
|
|
Forward Dividend
|
|
Dividend Yield
|
|
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
7 Binary Options
|
Your Ad Here
|
|